Full name
WYTWÓRNIA SUROWIC I SZCZEPIONEK BIOMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.76.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.73.Z - Retail sale of pharmaceutical products
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 13,5 | 16,1 | 17,4 | 8,3 |
Gross profit (loss) | 3,8 | 5,6 | 3,4 | -40,2 |
Net profit (loss) | 3,1 | 4,5 | 2,7 | -40,3 |
Cash | 0,5 | 1,5 | 0,9 | -43,5 |
Liabilities and provisions for liabilities | 7,2 | 6,1 | 5,5 | -10,3 |
Net income from sale | 15,6 | 19,4 | 17,7 | -8,5 |
Short time liabilities | 5 | 3,8 | 3,9 | 3,3 |
Working assets | 6,1 | 8,7 | 10,2 | 17,1 |
Equity capital | 6,3 | 9,9 | 11,9 | 19,8 |
Operating profit (EBIT) | 4,1 | 6 | 3,7 | -37,4 |
% | % | % | p.p. | |
Equity capital to total assets | 46,5 | 61,8 | 68,4 | 6,6 |
Gross profit margin | 24,5 | 29,1 | 19,1 | -10 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 116 | 72 | 81 | 9 |
Current financial liquidity indicator | 1.1227564811706543 | 1.7596397399902344 | 2.0049097537994385 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane